𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

✍ Scribed by Westermann, J; Flörcken, A; Willimsky, G; van Lessen, A; Kopp, J; Takvorian, A; Jöhrens, K; Lukowsky, A; Schönemann, C; Sawitzki, B

Book ID
109855399
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
715 KB
Volume
18
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase-I clinical study of autologous t
A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer
✍ Hendrik Veelken; Andreas Mackensen; Michael Lahn; Gabriele Köhler; Daniel Becker 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 257 KB 👁 2 views

Tumor cells transfected to express immunostimulatory cytokines, or admixed with similarly modified bystander cells, are able to induce immune responses against unmodified tumor cells in animal models. For treatment of human patients, a vaccine composed of autologous tumor cells and IL-2-secreting al